Ensemble Docking Approach to Mitigate Pregnane X Receptor-Mediated CYP3A4 Induction Risk

被引:0
|
作者
Chen, Qi [5 ]
Zhou, Xin [1 ]
Rehmel, Jessica [1 ]
Steele, James P. [2 ]
Svensson, Kjell A. [3 ]
Beck, James P. [4 ]
Hembre, Erik J. [5 ]
Hao, Junliang [4 ]
机构
[1] Eli Lilly & Co, Lilly Biotechnol Ctr, Drug Disposit, San Diego, CA 92121 USA
[2] Eli Lilly & Co, Lilly Biotechnol Ctr, Quantitat Biol, San Diego, CA 92121 USA
[3] Eli Lilly & Co, Lilly Biotechnol Ctr, Neurosci Discovery, San Diego, CA 92121 USA
[4] Eli Lilly & Co, Lilly Biotechnol Ctr, Discovery Chem Res & Technol, San Diego, CA 92121 USA
[5] Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA
关键词
INHIBITORS OPTIMIZING POTENCY; SUBTYPE-SELECTIVE AGENTS; POTENTIAL THERAPEUTICS; COACTIVATOR BINDING; CRYSTAL-STRUCTURE; RECENT PROGRESS; PXR; DISCOVERY; COMPLEX; SULFONAMIDES;
D O I
10.1021/acs.jcim.2c01175
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Three structurally closely related dopamine D1 receptor positive allosteric modulators (D1 PAMs) based on a tetrahydroisoquinoline (THIQ) scaffold were profiled for their CYP3A4 induction potentials. It was found that the length of the linker at the C5 position greatly affected the potentials of these D1 PAMs as CYP3A4 inducers, and the level of induction correlated well with the activation of the pregnane X receptor (PXR). Based on the published PXR X-ray crystal structures, we built a binding model specifically for these THIQ-scaffold-based D1 PAMs in the PXR ligand-binding pocket via an ensemble docking approach and found the model could explain the observed CYP induction disparity. Combined with our previously reported D1 receptor homology model, which identified the C5 position as pointing toward the solvent-exposed space, our PXR-binding model coincidentally suggested that structural modifications at the C5 position could productively modulate the CYP induction potential while maintaining the D1 PAM potency of these THIQ-based PAMs.
引用
收藏
页码:173 / 186
页数:14
相关论文
共 50 条
  • [21] Pregnane X Receptor and Yin Yang 1 Contribute to the Differential Tissue Expression and Induction of CYP3A5 and CYP3A4
    Barknowitz, G.
    Engst, W.
    Monien, B. H.
    Lehmann, C.
    Lippmann, D.
    Florian, S.
    Haack, M.
    Brigelius-Flohe, R.
    Glatt, H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 8 - 8
  • [22] Allelic variation of the pregnane X receptor (PXR) and CYP3A4 activity.
    Gaedigk, A
    Feldmeyer, J
    Czerwinski, M
    Parkinson, A
    Leeder, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P61 - P61
  • [23] Pregnane X Receptor and Yin Yang 1 Contribute to the Differential Tissue Expression and Induction of CYP3A5 and CYP3A4
    Baranyai, D.
    Nem, D.
    Qiu, H.
    Goedtel-Armbrust, U.
    Nestler, S.
    Wojnowski, L.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 8 - 8
  • [24] Pregnane X Receptor: Prediction and Attenuation of Human CYP3A4 Enzyme Induction and Drug-Drug Interactions
    Sinz, Michael W.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 43, 2008, 43 : 405 - 418
  • [25] Effects of liver X receptor agonists on human pregnane X receptor activity and CYP3A4 expression
    Duniec-Dmuchowski, Zofia
    Kocarek, Thomas A.
    FASEB JOURNAL, 2007, 21 (06): : A1182 - A1183
  • [26] Induction of CYP3A4 and MDR1 gene expression by baicalin, baicalein, chlorogenic acid, and ginsenoside Rf through constitutive androstane receptor- and pregnane X receptor-mediated pathways
    Li, Yue
    Wang, Qi
    Yao, Xiaomin
    Li, Yan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 640 (1-3) : 46 - 54
  • [27] Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development
    Sinz, Michael W.
    DRUG METABOLISM REVIEWS, 2013, 45 (01) : 3 - 14
  • [28] Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element
    El-Sankary, W
    Bombail, V
    Gibson, GG
    Plant, N
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (09) : 1029 - 1034
  • [29] Comparison of two immortalized human cell lines to study nuclear receptor-mediated CYP3A4 induction
    Harmsen, S.
    Koster, A. S.
    Beijnen, J. H.
    Schellens, J. H. M.
    Meijerman, I.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (06) : 1166 - 1171
  • [30] Endosulfan induces CYP2B6 and CYP3A4 by activating the pregnane X receptor
    Casabar, Richard C. T.
    Das, Parikshit C.
    DeKrey, Gregory K.
    Gardiner, Catherine S.
    Cao, Yan
    Rose, Randy L.
    Wallace, Andrew D.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2010, 245 (03) : 335 - 343